Swanson KD
Swanson KD
Beth Israel Deaconess Medical Center
Verified email at bidmc.harvard.edu
TitleCited byYear
Evidence for an alternative glycolytic pathway in rapidly proliferating cells
MG Vander Heiden, JW Locasale, KD Swanson, H Sharfi, GJ Heffron, ...
Science 329 (5998), 1492-1499, 2010
5572010
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
AE Roberts, T Araki, KD Swanson, KT Montgomery, TA Schiripo, VA Joshi, ...
Nature genetics 39 (1), 70, 2007
5282007
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
MI Kontaridis, KD Swanson, FS David, D Barford, BG Neel
Journal of Biological Chemistry 281 (10), 6785-6792, 2006
2892006
AR and ER interaction with a p21-activated kinase (PAK6)
SR Lee, SM Ramos, A Ko, D Masiello, KD Swanson, ML Lu, SP Balk
Molecular endocrinology 16 (1), 85-99, 2002
1692002
SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages
JF Timms, KD Swanson, A Marie-Cardine, M Raab, CE Rudd, B Schraven, ...
Current biology 9 (16), 927-S4, 1999
1001999
Phosphatase-dependent and-independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis
RA Stewart, T Sanda, HR Widlund, S Zhu, KD Swanson, AD Hurley, ...
Developmental cell 18 (5), 750-762, 2010
922010
The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair
B Li, AP Castano, TE Hudson, BT Nowlin, SL Lin, JV Bonventre, ...
The FASEB Journal 24 (12), 4767-4781, 2010
882010
ATP-stimulated Activation of the Mitogen-activated Protein Kinases through Ionotrophic P2X2 Purinoreceptors in PC12 Cells DIFFERENCE IN PURINORECEPTOR SENSITIVITY IN TWO PC12 …
KD Swanson, C Reigh, GE Landreth
Journal of Biological Chemistry 273 (32), 19965-19971, 1998
791998
Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit
N Gera, A Yang, TS Holtzman, SX Lee, ET Wong, KD Swanson
PLoS One 10 (5), e0125269, 2015
732015
Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM
M Togni, KD Swanson, S Reimann, S Kliche, AC Pearce, L Simeoni, ...
Molecular and cellular biology 25 (18), 8052-8063, 2005
732005
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
ET Wong, E Lok, S Gautam, KD Swanson
British journal of cancer 113 (2), 232, 2015
672015
SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients
KD Swanson, JM Winter, M Reis, M Bentires‐Alj, H Greulich, R Grewal, ...
Genes, Chromosomes and Cancer 47 (3), 253-259, 2008
582008
Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma
JW Locasale, T Melman, S Song, X Yang, KD Swanson, LC Cantley, ...
Molecular & Cellular Proteomics 11 (6), M111. 014688, 2012
572012
Androgen receptor enhances p27 degradation in prostate cancer cells through rapid and selective TORC2 activation
Z Fang, T Zhang, N Dizeyi, S Chen, H Wang, KD Swanson, C Cai, ...
Journal of Biological Chemistry 287 (3), 2090-2098, 2012
562012
Transcription Factor Phosphorylation by pp90 rsk2 IDENTIFICATION OF Fos KINASE AND NGFI-B KINASE I AS pp90 rsk2
KD Swanson, LK Taylor, L Haung, AL Burlingame, GE Landreth
Journal of Biological Chemistry 274 (6), 3385-3395, 1999
541999
Response assessment of NovoTTF‐100A versus best physician's choice chemotherapy in recurrent glioblastoma
ET Wong, E Lok, KD Swanson, S Gautam, HH Engelhard, F Lieberman, ...
Cancer medicine 3 (3), 592-602, 2014
392014
Cabozantinib eradicates advanced murine prostate cancer by activating antitumor innate immunity
A Patnaik, KD Swanson, E Csizmadia, A Solanki, N Landon-Brace, ...
Cancer discovery 7 (7), 750-765, 2017
372017
Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma
SH Kim, M Li, S Trousil, Y Zhang, MP di Magliano, KD Swanson, B Zheng
Journal of Investigative Dermatology 137 (8), 1740-1748, 2017
332017
Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement
FJ Alenghat, QJ Baca, NT Rubin, LI Pao, T Matozaki, CA Lowell, ...
J Cell Sci 125 (22), 5535-5545, 2012
322012
An overview of alternating electric fields therapy (NovoTTF Therapy) for the treatment of malignant glioma
KD Swanson, E Lok, ET Wong
Current neurology and neuroscience reports 16 (1), 8, 2016
312016
The system can't perform the operation now. Try again later.
Articles 1–20